GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 106 filers reported holding GENOMIC HEALTH INC in Q3 2014. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $4,037,000 | +3.0% | 128,200 | -3.9% | 0.01% | 0.0% |
Q4 2016 | $3,919,000 | -11.2% | 133,360 | -12.6% | 0.01% | -11.1% |
Q3 2016 | $4,411,000 | +13.8% | 152,520 | +1.9% | 0.01% | 0.0% |
Q2 2016 | $3,876,000 | -2.9% | 149,700 | -7.1% | 0.01% | 0.0% |
Q1 2016 | $3,993,000 | -29.8% | 161,200 | -0.3% | 0.01% | -30.8% |
Q4 2015 | $5,691,000 | +61.4% | 161,670 | -3.0% | 0.01% | +44.4% |
Q3 2015 | $3,527,000 | -23.8% | 166,660 | 0.0% | 0.01% | -18.2% |
Q2 2015 | $4,631,000 | -16.4% | 166,660 | -8.1% | 0.01% | -15.4% |
Q1 2015 | $5,537,000 | -14.1% | 181,260 | -10.1% | 0.01% | -13.3% |
Q4 2014 | $6,446,000 | -4.2% | 201,620 | -15.2% | 0.02% | -6.2% |
Q3 2014 | $6,730,000 | -4.7% | 237,720 | -7.8% | 0.02% | 0.0% |
Q2 2014 | $7,064,000 | -1.2% | 257,820 | -5.0% | 0.02% | -5.9% |
Q1 2014 | $7,148,000 | -11.9% | 271,370 | -2.1% | 0.02% | -15.0% |
Q4 2013 | $8,113,000 | +0.4% | 277,170 | +4.9% | 0.02% | -9.1% |
Q3 2013 | $8,078,000 | -7.6% | 264,170 | -4.1% | 0.02% | -12.0% |
Q2 2013 | $8,739,000 | – | 275,600 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 11,744,010 | $756,432,000 | 6.19% |
EMORY UNIVERSITY | 30,319 | $1,953,000 | 1.54% |
Copper Rock Capital Partners, LLC | 292,596 | $18,630,000 | 1.46% |
DE BURLO GROUP INC | 73,600 | $4,740,000 | 1.06% |
Eversept Partners, LP | 23,866 | $1,537,209 | 0.83% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 165,310 | $10,648,000 | 0.83% |
Aurora Investment Counsel | 20,916 | $1,347,000 | 0.73% |
Texas Children's | 8,035 | $518,000 | 0.72% |
Capital Impact Advisors, LLC | 24,665 | $1,570,000 | 0.67% |
Granahan Investment Management | 130,650 | $8,415,000 | 0.60% |